ASCIA anaphylaxis e-training for pharmacists

ASCIA anaphylaxis e-training for pharmacists has been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA) to provide ready access to reliable anaphylaxis education for pharmacists throughout Australia and New Zealand, at no charge. 

Development of ASCIA anaphylaxis e-training has included an extensive review process which involved ASCIA members as well as representatives from other key stakeholder organisations throughout Australasia. 

ASCIA anaphylaxis e-training for pharmacists has been updated to Version 8.2 | 16 January 2024 and contains:

• Current ASCIA Action and First Aid Plans.
  
• Current infographics and animations to make the training more visual and interactive.
• Instructions for two brands of adrenaline (epinephrine) injectors, EpiPen® and Anapen®.
  

Version 8.2 allows for participants who are required to complete this course annually.

ASCIA anaphylaxis e-training for pharmacists Version 8.1 incorporated:

• Updated and new ASCIA Action and First Aid Plans.
• New infographics and animations to make the training more visual and interactive.
• Instructions for two brands of adrenaline (epinephrine) injectors, EpiPen® and Anapen® (available on the PBS September 2021).

CPD Points apply

ASCIA anaphylaxis e-training for pharmacists takes approximately 1.5 hours to complete. It can be self-recorded on an individual pharmacist’s CPD plan for 1.5 hours of Group 1 CPD (or 1.5 CPD credits), which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities and e-training completion. 

Read more about self-recording CPD from the Pharmacy Board: https://www.pharmacyboard.gov.au/codes-guidelines/faq/cpd-faq.aspx 

Pharmacist CPD credits

Group 1: 1.50

Group 2: 3.00

ASCIA Anaphylaxis refresher e-training 2024

This course is suitable for Pharmacists and other healthcare professionals.

This course should be used to upskill or as interim refresher training. It does not replace the comprehensive ASCIA Anaphylaxis e-training course for pharmacists, which take around 1.5 hours to complete and include detailed modules about epidemiology, diagnosis, acute management of anaphylaxis and allergy to stings and bites.

This course is part of an education project that has received funding from the Australian Government, Department of Health, since July 2022. ASCIA also acknowledges other supporters of ASCIA education initiatives.

The learning outcomes for this course are: 

1. Differentiate between a mild to moderate allergic reaction and anaphylaxis.

2. Outline acute management for mild or moderate allergic reactions and anaphylaxis.

Go to Refresher course >>>